Medacta commenced commercial launch of 3DMetal™ Femoral Cones for revision knee procedures, following FDA 510(k) clearance and approval under the CE Mark.
The cones can be used for structural support in areas of bone deficiencies that may compromise implant fixation, and are indicated for use with Medacta’s GMK Revision and GMK Hinge Knee systems (pictured above, left to right).
3DMetal Femoral Cones feature a triple layer structure, patented by Medacta, with a middle full-density layer to avoid cement protrusion through the outer layer pores. The interconnecting pore structure of these implants, similar to that of native cancellous bone, supports direct mechanical and functional connection with the bone.
Medacta’s offering for knee arthroplasty now offers a broader range of options for revision surgery and complex cases.
Medacta commenced commercial launch of 3DMetal™ Femoral Cones for revision knee procedures, following FDA 510(k) clearance and approval under the CE Mark.
The cones can be used for structural support in areas of bone deficiencies that may compromise implant fixation, and are indicated for use with Medacta's GMK Revision and GMK Hinge Knee...
Medacta commenced commercial launch of 3DMetal™ Femoral Cones for revision knee procedures, following FDA 510(k) clearance and approval under the CE Mark.
The cones can be used for structural support in areas of bone deficiencies that may compromise implant fixation, and are indicated for use with Medacta’s GMK Revision and GMK Hinge Knee systems (pictured above, left to right).
3DMetal Femoral Cones feature a triple layer structure, patented by Medacta, with a middle full-density layer to avoid cement protrusion through the outer layer pores. The interconnecting pore structure of these implants, similar to that of native cancellous bone, supports direct mechanical and functional connection with the bone.
Medacta’s offering for knee arthroplasty now offers a broader range of options for revision surgery and complex cases.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
